Wellstar/TMI Announces Completion of HIPAA Compliance Guideline and Procedures
07 Janvier 2009 - 12:06AM
Marketwired
Wellstar International, Inc. (OTCBB: WLSI), a provider of
specialized diagnostic software and equipment, today announced the
completion of their Health Insurance Portability and Accountability
Act ("HIPAA") compliance guideline and procedures. Wellstar's
wholly-owned subsidiary, Trillennium Medical Imaging ("TMI"), has
developed a fully calibrated and functional, thermal imaging system
that utilizes state-of-the-art infrared technologies and
proprietary software to accurately and cost-effectively measure
physiological changes in the human body. TMI's primary application
for their system is the early detection of pressure ulcers.
Wellstar and TMI have taken every step possible to ensure that
all protected health information (known as Electronic Protected
Health Information or EPHI), which is created, stored, transmitted
or received electronically as a result of the Company's thermal
imaging system being utilized by healthcare and long-term care
facilities, is completely secure and encrypted -- which is achieved
by assigning each patient a 30-digit numerical value and bar code
through the use of TMI's proprietary software.
TMI's vice president of operations, Brian Brooks, stated: "By
securing the identity of each patient, TMI can effectively and
objectively compare and contrast all patterns of injury associated
with the development of pressure ulcers, without compromising
patient information. This will allow us to continue to gather
valuable data that will help further define these markers."
ABOUT WELLSTAR INTERNATIONAL, INC.:
Wellstar International, Inc., through its wholly owned operating
subsidiary Trillenium Medical Imaging, Inc. (TMI), is poised to
become a leading diagnostic company in the health care industry.
TMI has developed and is marketing fully calibrated and functional,
thermal imaging systems that utilize state-of-the-art infrared
technologies and proprietary software to accurately and
cost-effectively measure physiological changes in the human body.
More information on the Company and its unique diagnostic software
and product line is available on Wellstar's corporate Website, by
visiting: www.wellstar.us.
FORWARD-LOOKING STATEMENTS:
This press release contains statements, which may constitute
'forward-looking statements' within the meaning of the Securities
Act of 1933 and the Securities Exchange Act of 1934, as amended by
the Private Securities Litigation Reform Act of 1995. Prospective
investors are cautioned that any such forward-looking statements
are not guarantees of future performance and involve risks and
uncertainties, and that actual results may differ materially from
those contemplated by such forward-looking statements. Important
factors currently known to management that could cause actual
results to differ materially from those in forward-looking
statements include fluctuation of operating results, the ability to
compete successfully and the ability to complete before-mentioned
transactions. The company undertakes no obligation to update or
revise forward-looking statements to reflect changed assumptions,
the occurrence of unanticipated events or changes to future
operating results.
CONTACT: Equiti-trend Advisors LLC (800) 953-3350 Toll-Free,
U.S. & Canada (858) 436-3350 Local or International 9:30 a.m.
to 5:00 p.m. Daily
Wellstar (CE) (USOTC:WLSI)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Wellstar (CE) (USOTC:WLSI)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024